跳至主要内容
临床试验/NCT04396938
NCT04396938已完成不适用

The Effect of a Single Dose of Lamotrigine on Brain Function in Healthy Volunteers

University of Oxford1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2017年5月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Neural function

研究概览

简要总结

This study will test whether a single dose of Lamotrigine (300mg) exerts significant effects on emotional processing, cognitive ability and neural activity in healthy volunteers compared to placebo.

详细描述

Glutamate has been implicated in the aetiology of mood disorders and there is current interest in developing novel agents targeting this system. However, the role of glutamate in human emotional function is relatively unknown. Lamotrigine's pharmacological profile involves a blockade of voltage-gated sodium channels, leading to an inhibition in the release of glutamate and resulting in a general inhibitory effect on cortical neuronal function.

The current study plans to investigate the effects of modifying glutamate on emotional processing, cognitive function and neural activity. For this, 36 healthy volunteers will be recruited to the study and randomised to receive a single dose of lamotrigine (300 mg) or placebo. Two hours after drug administration, the effects of emotional processing via the use of cognitive tasks will be assessed using fMRI. This will be followed by an emotional test battery that will measure aspects of cognitive function as well.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female
  • •Aged 18-40 years
  • •Willing and able to give informed consent for participation in the study
  • •Sufficiently fluent English to understand and complete the task

排除标准

  • •Current usage of psychoactive medication
  • •Current usage of the contraceptive pill
  • •Any past or current Axis 1 DSM-IV psychiatric disorder
  • •Significant medical condition
  • •Current pregnancy or breastfeeding
  • •Current or past history of drug or alcohol dependency
  • •Participation in a psychological or medical study involving the use of medication within the last 3 months
  • •Previous participation in a study using the same, or similar, emotional processing tasks
  • •Smoker > 5 cigarettes per day
  • •Typically drinks > 6 caffeinated drinks per day
  • •Takes folic acid supplements
  • •History of recurrent allergies and rashes
  • •Contraindication to MRI (e.g. claustrophobia and metallic implants)

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo capsule: identical appearance to experimental capsule. In healthy volunteers.

干预措施: Placebos (Drug)

Lamotrigine

Experimental

Single dose of Lamotrigine (300mg - capsule). In healthy volunteers.

干预措施: Lamotrigine (Drug)

结局指标

主要结局

Neural function

时间窗: Data reporting and analysis to be completed within 1 year following study completion.

fMRI checkerboard analysis

次要结局

  • Emotional Processing and Cognitive Function(Data reporting and analysis to be completed within 6 months following study completion.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验